{"transactions":[{"id":2190926,"issuer":{"id":4949,"kind":"organization","name":"Aeva Technologies, Inc.","symbol":"AEVA"},"owners":[{"id":67487,"kind":"person","name":"Hebert Peter","position":1,"cik":"0001683771","reported_name":"Hebert Peter","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67419,"kind":"person","name":"Wolfe Josh","position":2,"cik":"0001830001","reported_name":"Wolfe Josh","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124765,"kind":"organization","name":"Lux Ventures IV, L.P.","position":3,"cik":"0001633331","reported_name":"Lux Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124766,"kind":"organization","name":"Lux Co-Invest Opportunities, L.P.","position":4,"cik":"0001722022","reported_name":"Lux Co-Invest Opportunities, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124767,"kind":"organization","name":"Lux Venture Partners IV, LLC","position":5,"cik":"0001633332","reported_name":"Lux Venture Partners IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124768,"kind":"organization","name":"Lux Co-Invest Partners, LLC","position":6,"cik":"0001722021","reported_name":"Lux Co-Invest Partners, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-08-09T17:01:48.000Z","date":"2022-08-05","kind":"other","acquired":false,"shares":7346159,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pro rata distribution from Lux Ventures IV, L.P. to its partners. Lux Venture Partners IV, LLC is the general partner of Lux Ventures IV, L.P. and exercises voting and dispositive power over the shares noted herein held by Lux Ventures IV, L.P. Peter Hebert and Josh Wolfe are the individual managing members of Lux Venture Partners IV, LLC (the \"Individual Lux Managers\"). The Individual Lux Managers, as the sole managers of Lux Venture Partners IV, LLC, may be deemed to share voting and dispositive power for the shares noted herein held by Lux Ventures IV, L.P. Each of Lux Venture Partners IV, LLC and the Individual Lux Managers separately disclaim beneficial ownership over the shares noted herein except to the extent of their pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Pro rata distribution from Lux Ventures IV, L.P. to its partners. Lux Venture Partners IV, LLC is the general partner of Lux Ventures IV, L.P. and exercises voting and dispositive power over the shares noted herein held by Lux Ventures IV, L.P. Peter Hebert and Josh Wolfe are the individual managing members of Lux Venture Partners IV, LLC (the \"Individual Lux Managers\"). The Individual Lux Managers, as the sole managers of Lux Venture Partners IV, LLC, may be deemed to share voting and dispositive power for the shares noted herein held by Lux Ventures IV, L.P. Each of Lux Venture Partners IV, LLC and the Individual Lux Managers separately disclaim beneficial ownership over the shares noted herein except to the extent of their pecuniary interest therein."}],"balance_after":14692316,"source":{"system":"sec-edgar","filing":"0001493152-22-021786","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1722021/000149315222021786/ownership.xml","form_type":"4"}},{"id":2302698,"issuer":{"id":15235,"kind":"organization","name":"Science 37 Holdings, Inc.","symbol":"SNCE"},"owners":[{"id":128249,"kind":"organization","name":"Lux Capital Management, LLC","position":1,"cik":"0001592843","reported_name":"Lux Capital Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124765,"kind":"organization","name":"Lux Ventures IV, L.P.","position":2,"cik":"0001633331","reported_name":"Lux Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124767,"kind":"organization","name":"Lux Venture Partners IV, LLC","position":3,"cik":"0001633332","reported_name":"Lux Venture Partners IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124766,"kind":"organization","name":"Lux Co-Invest Opportunities, L.P.","position":4,"cik":"0001722022","reported_name":"Lux Co-Invest Opportunities, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124768,"kind":"organization","name":"Lux Co-Invest Partners, LLC","position":5,"cik":"0001722021","reported_name":"Lux Co-Invest Partners, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67487,"kind":"person","name":"Hebert Peter","position":6,"cik":"0001683771","reported_name":"Hebert Peter","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67419,"kind":"person","name":"Wolfe Josh","position":7,"cik":"0001830001","reported_name":"Wolfe Josh","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-04-06T20:43:20.000Z","date":"2022-04-04","kind":"other","acquired":false,"shares":2914667,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Lux Ventures IV, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pro rata distribution of 2,914,667 shares from Lux Ventures IV, L.P. to its partners."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Lux Venture Partners IV, LLC is the general partner of Lux Ventures IV, L.P. and exercises voting and dispositive power over the shares held by Lux Ventures IV, L.P. Lux Co-Invest Partners, LLC is the general partner of Lux Co-Invest Opportunities, L.P. and exercises voting and dispositive power over the shares held by Lux Co-Invest Opportunities, L.P. Peter Hebert and Joshua Wolfe are the individual managers of Lux Venture Partners IV, LLC and Lux Co-Invest Partners, LLC and may be deemed to share voting and dispositive power over the shares held by each of Lux Ventures IV, L.P. and Lux Co-Invest Opportunities, L.P., Lux Capital Management, LLC, as the investment manager for each of Lux Venture Partners IV, LLC and Lux Co-Invest Partners, LLC, may be deemed to share voting and dispositive power over the shares held by each of Lux Ventures IV, L.P. and Lux Co-Invest Opportunities, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Each of Lux Capital Management, LLC, Lux Venture Partners IV, LLC, Lux Co-Invest Partners, LLC, Peter Hebert and Joshua Wolfe disclaim beneficial ownership over the shares reported herein except to the extent of their pecuniary interest therein, if any."}],"balance_after":8743999,"source":{"system":"sec-edgar","filing":"0000905718-22-000545","document":"science_fm4apr42022.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819113/000090571822000545/science_fm4apr42022.xml","form_type":"4"}},{"id":2478983,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":124765,"kind":"organization","name":"Lux Ventures IV, L.P.","position":1,"cik":"0001633331","reported_name":"Lux Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}},{"id":124767,"kind":"organization","name":"Lux Venture Partners IV, LLC","position":2,"cik":"0001633332","reported_name":"Lux Venture Partners IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}},{"id":124766,"kind":"organization","name":"Lux Co-Invest Opportunities, L.P.","position":3,"cik":"0001722022","reported_name":"Lux Co-Invest Opportunities, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}},{"id":124768,"kind":"organization","name":"Lux Co-Invest Partners, LLC","position":4,"cik":"0001722021","reported_name":"Lux Co-Invest Partners, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}},{"id":67487,"kind":"person","name":"Hebert Peter","position":5,"cik":"0001683771","reported_name":"Hebert Peter","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}},{"id":67419,"kind":"person","name":"Wolfe Josh","position":6,"cik":"0001830001","reported_name":"Wolfe Josh","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}}],"security":"Class A common stock","published_at":"2021-12-09T20:57:21.000Z","date":"2021-12-07","kind":"other","acquired":false,"shares":4265576,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pro rata distribution from Lux Ventures IV, L.P. to its partners. Lux Venture Partners IV, LLC is the general partner of Lux Ventures IV, L.P. and exercises voting and dispositive power over the shares noted herein held by Lux Ventures IV, L.P. Peter Hebert and Josh Wolfe are the individual managing members of Lux Venture Partners IV, LLC (the \"Individual Lux Managers\"). The Individual Lux Managers, as the sole managers of Lux Venture Partners IV, LLC, may be deemed to share voting and dispositive power for the shares noted herein held by Lux Ventures IV, L.P. Each of Lux Venture Partners IV, LLC and the Individual Lux Managers separately disclaim beneficial ownership over the shares noted herein except to the extent of their pecuniary interest therein."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Pro rata distribution from Lux Ventures IV, L.P. to its partners. Lux Venture Partners IV, LLC is the general partner of Lux Ventures IV, L.P. and exercises voting and dispositive power over the shares noted herein held by Lux Ventures IV, L.P. Peter Hebert and Josh Wolfe are the individual managing members of Lux Venture Partners IV, LLC (the \"Individual Lux Managers\"). The Individual Lux Managers, as the sole managers of Lux Venture Partners IV, LLC, may be deemed to share voting and dispositive power for the shares noted herein held by Lux Ventures IV, L.P. Each of Lux Venture Partners IV, LLC and the Individual Lux Managers separately disclaim beneficial ownership over the shares noted herein except to the extent of their pecuniary interest therein."}],"balance_after":13021519,"source":{"system":"sec-edgar","filing":"0000905718-21-001582","document":"recursion_fm4dec72021.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1722021/000090571821001582/recursion_fm4dec72021.xml","form_type":"4"}},{"id":2549090,"issuer":{"id":9606,"kind":"organization","name":"Latch, Inc.","symbol":"LTCH"},"owners":[{"id":124765,"kind":"organization","name":"Lux Ventures IV, L.P.","position":1,"cik":"0001633331","reported_name":"Lux Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124767,"kind":"organization","name":"Lux Venture Partners IV, LLC","position":2,"cik":"0001633332","reported_name":"Lux Venture Partners IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124766,"kind":"organization","name":"Lux Co-Invest Opportunities, L.P.","position":3,"cik":"0001722022","reported_name":"Lux Co-Invest Opportunities, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124768,"kind":"organization","name":"Lux Co-Invest Partners, LLC","position":4,"cik":"0001722021","reported_name":"Lux Co-Invest Partners, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67487,"kind":"person","name":"Hebert Peter","position":5,"cik":"0001683771","reported_name":"Hebert Peter","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67419,"kind":"person","name":"Wolfe Josh","position":6,"cik":"0001830001","reported_name":"Wolfe Josh","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-10-05T16:31:46.000Z","date":"2021-09-28","kind":"other","acquired":false,"shares":1358164,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Pro rata distribution from Lux Co-Invest Opportunities, L.P. to its partners. Lux Co-Invest Partners, LLC is the general partner of Lux Co-Invest Opportunities, L.P. and exercises voting and dispositive power over the shares noted herein held by Lux Co-Invest Opportunities, L.P. The Individual Lux Managers are the individual managing members of Lux Co-Invest Partners, LLC. The Individual Lux Managers, as the sole managers of Lux Co-Invest Partners, LLC, may be deemed to share voting and dispositive power for the shares noted herein held by Lux Co-Invest Opportunities, L.P. Each of Lux Co-Invest Partners, LLC and the Individual Lux Managers separately disclaim beneficial ownership over the shares noted herein except to the extent of their pecuniary interest."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Pro rata distribution from Lux Co-Invest Opportunities, L.P. to its partners. Lux Co-Invest Partners, LLC is the general partner of Lux Co-Invest Opportunities, L.P. and exercises voting and dispositive power over the shares noted herein held by Lux Co-Invest Opportunities, L.P. The Individual Lux Managers are the individual managing members of Lux Co-Invest Partners, LLC. The Individual Lux Managers, as the sole managers of Lux Co-Invest Partners, LLC, may be deemed to share voting and dispositive power for the shares noted herein held by Lux Co-Invest Opportunities, L.P. Each of Lux Co-Invest Partners, LLC and the Individual Lux Managers separately disclaim beneficial ownership over the shares noted herein except to the extent of their pecuniary interest."}],"balance_after":4084493,"source":{"system":"sec-edgar","filing":"0000905718-21-001276","document":"latch_fm4sep282021.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1722021/000090571821001276/latch_fm4sep282021.xml","form_type":"4"}},{"id":2549089,"issuer":{"id":9606,"kind":"organization","name":"Latch, Inc.","symbol":"LTCH"},"owners":[{"id":124765,"kind":"organization","name":"Lux Ventures IV, L.P.","position":1,"cik":"0001633331","reported_name":"Lux Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124767,"kind":"organization","name":"Lux Venture Partners IV, LLC","position":2,"cik":"0001633332","reported_name":"Lux Venture Partners IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124766,"kind":"organization","name":"Lux Co-Invest Opportunities, L.P.","position":3,"cik":"0001722022","reported_name":"Lux Co-Invest Opportunities, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124768,"kind":"organization","name":"Lux Co-Invest Partners, LLC","position":4,"cik":"0001722021","reported_name":"Lux Co-Invest Partners, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67487,"kind":"person","name":"Hebert Peter","position":5,"cik":"0001683771","reported_name":"Hebert Peter","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67419,"kind":"person","name":"Wolfe Josh","position":6,"cik":"0001830001","reported_name":"Wolfe Josh","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-10-05T16:31:46.000Z","date":"2021-09-28","kind":"other","acquired":false,"shares":2409489,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pro rata distribution from Lux Ventures IV, L.P. to its partners. Lux Venture Partners IV, LLC is the general partner of Lux Ventures IV, L.P. and exercises voting and dispositive power over the shares noted herein held by Lux Ventures IV, L.P. Peter Hebert and Josh Wolfe are the individual managing members of Lux Venture Partners IV, LLC (the \"Individual Lux Managers\"). The Individual Lux Managers, as the sole managers of Lux Venture Partners IV, LLC, may be deemed to share voting and dispositive power for the shares noted herein held by Lux Ventures IV, L.P. Each of Lux Venture Partners IV, LLC and the Individual Lux Managers separately disclaim beneficial ownership over the shares noted herein except to the extent of their pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Pro rata distribution from Lux Ventures IV, L.P. to its partners. Lux Venture Partners IV, LLC is the general partner of Lux Ventures IV, L.P. and exercises voting and dispositive power over the shares noted herein held by Lux Ventures IV, L.P. Peter Hebert and Josh Wolfe are the individual managing members of Lux Venture Partners IV, LLC (the \"Individual Lux Managers\"). The Individual Lux Managers, as the sole managers of Lux Venture Partners IV, LLC, may be deemed to share voting and dispositive power for the shares noted herein held by Lux Ventures IV, L.P. Each of Lux Venture Partners IV, LLC and the Individual Lux Managers separately disclaim beneficial ownership over the shares noted herein except to the extent of their pecuniary interest therein."}],"balance_after":7228469,"source":{"system":"sec-edgar","filing":"0000905718-21-001276","document":"latch_fm4sep282021.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1722021/000090571821001276/latch_fm4sep282021.xml","form_type":"4"}},{"id":2573300,"issuer":{"id":4949,"kind":"organization","name":"Aeva Technologies, Inc.","symbol":"AEVA"},"owners":[{"id":67487,"kind":"person","name":"Hebert Peter","position":1,"cik":"0001683771","reported_name":"Hebert Peter","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67419,"kind":"person","name":"Wolfe Josh","position":2,"cik":"0001830001","reported_name":"Wolfe Josh","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124765,"kind":"organization","name":"Lux Ventures IV, L.P.","position":3,"cik":"0001633331","reported_name":"Lux Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124766,"kind":"organization","name":"Lux Co-Invest Opportunities, L.P.","position":4,"cik":"0001722022","reported_name":"Lux Co-Invest Opportunities, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124767,"kind":"organization","name":"Lux Venture Partners IV, LLC","position":5,"cik":"0001633332","reported_name":"Lux Venture Partners IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124768,"kind":"organization","name":"Lux Co-Invest Partners, LLC","position":6,"cik":"0001722021","reported_name":"Lux Co-Invest Partners, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-09-10T16:56:50.000Z","date":"2021-09-08","kind":"other","acquired":false,"shares":7346159,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pro rata distribution from Lux Ventures IV, L.P. to its partners. Lux Venture Partners IV, LLC is the general partner of Lux Ventures IV, L.P. and exercises voting and dispositive power over the shares noted herein held by Lux Ventures IV, L.P. Peter Hebert and Josh Wolfe are the individual managing members of Lux Venture Partners IV, LLC (the \"Individual Lux Managers\"). The Individual Lux Managers, as the sole managers of Lux Venture Partners IV, LLC, may be deemed to share voting and dispositive power for the shares noted herein held by Lux Ventures IV, L.P. Each of Lux Venture Partners IV, LLC and the Individual Lux Managers separately disclaim beneficial ownership over the shares noted herein except to the extent of their pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Pro rata distribution from Lux Ventures IV, L.P. to its partners. Lux Venture Partners IV, LLC is the general partner of Lux Ventures IV, L.P. and exercises voting and dispositive power over the shares noted herein held by Lux Ventures IV, L.P. Peter Hebert and Josh Wolfe are the individual managing members of Lux Venture Partners IV, LLC (the \"Individual Lux Managers\"). The Individual Lux Managers, as the sole managers of Lux Venture Partners IV, LLC, may be deemed to share voting and dispositive power for the shares noted herein held by Lux Ventures IV, L.P. Each of Lux Venture Partners IV, LLC and the Individual Lux Managers separately disclaim beneficial ownership over the shares noted herein except to the extent of their pecuniary interest therein."}],"balance_after":22038475,"source":{"system":"sec-edgar","filing":"0000905718-21-001184","document":"aevatech_fm4sep82021.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1722021/000090571821001184/aevatech_fm4sep82021.xml","form_type":"4"}},{"id":2744044,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":124765,"kind":"organization","name":"Lux Ventures IV, L.P.","position":1,"cik":"0001633331","reported_name":"Lux Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124766,"kind":"organization","name":"Lux Co-Invest Opportunities, L.P.","position":2,"cik":"0001722022","reported_name":"Lux Co-Invest Opportunities, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124768,"kind":"organization","name":"Lux Co-Invest Partners, LLC","position":3,"cik":"0001722021","reported_name":"Lux Co-Invest Partners, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124767,"kind":"organization","name":"Lux Venture Partners IV, LLC","position":4,"cik":"0001633332","reported_name":"Lux Venture Partners IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series D Preferred Stock","published_at":"2021-04-20T21:30:12.000Z","date":"2021-04-20","kind":"exercise","acquired":false,"shares":1490783,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each share of Common Stock, Series A Preferred Stock, Series A-1 Preferred Stock, Series B Preferred Stock and Series D Preferred Stock automatically converted into Class A Common Stock on a 1:1 basis immediately prior to the completion of Recursion Pharmaceuticals, Inc.'s (the \"Issuer\") initial public offering of Class A Common Stock (the \"IPO\"). Each shares of Series C Preferred Stock automatically converted into Class A Common Stock on a 1.1869358:1 basis immediately prior to the completion of the Issuer's IPO. The right to convert Common Stock, Series A Preferred Stock, Series A-1 Preferred Stock, Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock into Class A Common Stock had no expiration date."},{"field":"shares","element":"transactionShares","label":"F10","text":"Represents 298,156 shares held of record by Lux Ventures IV, L.P. and 1,192,627 shares held of record by Lux Co-Invest Opportunities, L.P."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Each share of Common Stock, Series A Preferred Stock, Series A-1 Preferred Stock, Series B Preferred Stock and Series D Preferred Stock automatically converted into Class A Common Stock on a 1:1 basis immediately prior to the completion of Recursion Pharmaceuticals, Inc.'s (the \"Issuer\") initial public offering of Class A Common Stock (the \"IPO\"). Each shares of Series C Preferred Stock automatically converted into Class A Common Stock on a 1.1869358:1 basis immediately prior to the completion of the Issuer's IPO. The right to convert Common Stock, Series A Preferred Stock, Series A-1 Preferred Stock, Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock into Class A Common Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Each share of Common Stock, Series A Preferred Stock, Series A-1 Preferred Stock, Series B Preferred Stock and Series D Preferred Stock automatically converted into Class A Common Stock on a 1:1 basis immediately prior to the completion of Recursion Pharmaceuticals, Inc.'s (the \"Issuer\") initial public offering of Class A Common Stock (the \"IPO\"). Each shares of Series C Preferred Stock automatically converted into Class A Common Stock on a 1.1869358:1 basis immediately prior to the completion of the Issuer's IPO. The right to convert Common Stock, Series A Preferred Stock, Series A-1 Preferred Stock, Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock into Class A Common Stock had no expiration date."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F5","text":"Each share of Common Stock, Series A Preferred Stock, Series A-1 Preferred Stock, Series B Preferred Stock and Series D Preferred Stock automatically converted into Class A Common Stock on a 1:1 basis immediately prior to the completion of Recursion Pharmaceuticals, Inc.'s (the \"Issuer\") initial public offering of Class A Common Stock (the \"IPO\"). Each shares of Series C Preferred Stock automatically converted into Class A Common Stock on a 1.1869358:1 basis immediately prior to the completion of the Issuer's IPO. The right to convert Common Stock, Series A Preferred Stock, Series A-1 Preferred Stock, Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock into Class A Common Stock had no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F10","text":"Represents 298,156 shares held of record by Lux Ventures IV, L.P. and 1,192,627 shares held of record by Lux Co-Invest Opportunities, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Lux Co-Invest Partners, LLC is the general partner of Lux Co-Invest Opportunities, L.P. and exercises voting and dispositive power over the shares noted herein held by Lux Co-Invest Opportunities, L.P. Lux Venture Partners IV, LLC is the general partner of Lux Ventures IV, LP and exercises voting and dispositive power over the shares noted herein held by Lux Ventures IV, L.P. Peter Hebert and Josh Wolfe are the individual managing members of Lux Venture Partners IV, LLC and Lux Co-Invest Partners, LLC, or the Individual Managers. The Individual Managers, as the sole managers of Lux Venture Partners IV, LLC and Lux Co-Invest Partners, LLC, may be deemed to share voting and dispositive power for the shares noted herein held by Lux Ventures IV, L.P. and Lux Co-Invest Opportunities, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Each of Lux Venture Partners IV, LLC, Lux Co-Invest Partners, LLC, and the Individual Managers separately disclaim beneficial ownership over the shares noted herein except to the extent of their pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1490783},"source":{"system":"sec-edgar","filing":"0001209191-21-027701","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1722021/000120919121027701/doc4.xml","form_type":"4"}},{"id":2744043,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":124765,"kind":"organization","name":"Lux Ventures IV, L.P.","position":1,"cik":"0001633331","reported_name":"Lux Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124766,"kind":"organization","name":"Lux Co-Invest Opportunities, L.P.","position":2,"cik":"0001722022","reported_name":"Lux Co-Invest Opportunities, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124768,"kind":"organization","name":"Lux Co-Invest Partners, LLC","position":3,"cik":"0001722021","reported_name":"Lux Co-Invest Partners, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124767,"kind":"organization","name":"Lux Venture Partners IV, LLC","position":4,"cik":"0001633332","reported_name":"Lux Venture Partners IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Preferred Stock","published_at":"2021-04-20T21:30:12.000Z","date":"2021-04-20","kind":"exercise","acquired":false,"shares":1825883,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each share of Common Stock, Series A Preferred Stock, Series A-1 Preferred Stock, Series B Preferred Stock and Series D Preferred Stock automatically converted into Class A Common Stock on a 1:1 basis immediately prior to the completion of Recursion Pharmaceuticals, Inc.'s (the \"Issuer\") initial public offering of Class A Common Stock (the \"IPO\"). Each shares of Series C Preferred Stock automatically converted into Class A Common Stock on a 1.1869358:1 basis immediately prior to the completion of the Issuer's IPO. The right to convert Common Stock, Series A Preferred Stock, Series A-1 Preferred Stock, Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock into Class A Common Stock had no expiration date."},{"field":"shares","element":"transactionShares","label":"F9","text":"Represents shares held of record by Lux Co-Invest Opportunities, L.P."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Each share of Common Stock, Series A Preferred Stock, Series A-1 Preferred Stock, Series B Preferred Stock and Series D Preferred Stock automatically converted into Class A Common Stock on a 1:1 basis immediately prior to the completion of Recursion Pharmaceuticals, Inc.'s (the \"Issuer\") initial public offering of Class A Common Stock (the \"IPO\"). Each shares of Series C Preferred Stock automatically converted into Class A Common Stock on a 1.1869358:1 basis immediately prior to the completion of the Issuer's IPO. The right to convert Common Stock, Series A Preferred Stock, Series A-1 Preferred Stock, Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock into Class A Common Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Each share of Common Stock, Series A Preferred Stock, Series A-1 Preferred Stock, Series B Preferred Stock and Series D Preferred Stock automatically converted into Class A Common Stock on a 1:1 basis immediately prior to the completion of Recursion Pharmaceuticals, Inc.'s (the \"Issuer\") initial public offering of Class A Common Stock (the \"IPO\"). Each shares of Series C Preferred Stock automatically converted into Class A Common Stock on a 1.1869358:1 basis immediately prior to the completion of the Issuer's IPO. The right to convert Common Stock, Series A Preferred Stock, Series A-1 Preferred Stock, Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock into Class A Common Stock had no expiration date."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F5","text":"Each share of Common Stock, Series A Preferred Stock, Series A-1 Preferred Stock, Series B Preferred Stock and Series D Preferred Stock automatically converted into Class A Common Stock on a 1:1 basis immediately prior to the completion of Recursion Pharmaceuticals, Inc.'s (the \"Issuer\") initial public offering of Class A Common Stock (the \"IPO\"). Each shares of Series C Preferred Stock automatically converted into Class A Common Stock on a 1.1869358:1 basis immediately prior to the completion of the Issuer's IPO. The right to convert Common Stock, Series A Preferred Stock, Series A-1 Preferred Stock, Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock into Class A Common Stock had no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F9","text":"Represents shares held of record by Lux Co-Invest Opportunities, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Lux Co-Invest Partners, LLC is the general partner of Lux Co-Invest Opportunities, L.P. and exercises voting and dispositive power over the shares noted herein held by Lux Co-Invest Opportunities, L.P. Lux Venture Partners IV, LLC is the general partner of Lux Ventures IV, LP and exercises voting and dispositive power over the shares noted herein held by Lux Ventures IV, L.P. Peter Hebert and Josh Wolfe are the individual managing members of Lux Venture Partners IV, LLC and Lux Co-Invest Partners, LLC, or the Individual Managers. The Individual Managers, as the sole managers of Lux Venture Partners IV, LLC and Lux Co-Invest Partners, LLC, may be deemed to share voting and dispositive power for the shares noted herein held by Lux Ventures IV, L.P. and Lux Co-Invest Opportunities, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Each of Lux Venture Partners IV, LLC, Lux Co-Invest Partners, LLC, and the Individual Managers separately disclaim beneficial ownership over the shares noted herein except to the extent of their pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1825883},"source":{"system":"sec-edgar","filing":"0001209191-21-027701","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1722021/000120919121027701/doc4.xml","form_type":"4"}},{"id":2744042,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":124765,"kind":"organization","name":"Lux Ventures IV, L.P.","position":1,"cik":"0001633331","reported_name":"Lux Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124766,"kind":"organization","name":"Lux Co-Invest Opportunities, L.P.","position":2,"cik":"0001722022","reported_name":"Lux Co-Invest Opportunities, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124768,"kind":"organization","name":"Lux Co-Invest Partners, LLC","position":3,"cik":"0001722021","reported_name":"Lux Co-Invest Partners, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124767,"kind":"organization","name":"Lux Venture Partners IV, LLC","position":4,"cik":"0001633332","reported_name":"Lux Venture Partners IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Preferred Stock","published_at":"2021-04-20T21:30:12.000Z","date":"2021-04-20","kind":"exercise","acquired":false,"shares":3578653,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each share of Common Stock, Series A Preferred Stock, Series A-1 Preferred Stock, Series B Preferred Stock and Series D Preferred Stock automatically converted into Class A Common Stock on a 1:1 basis immediately prior to the completion of Recursion Pharmaceuticals, Inc.'s (the \"Issuer\") initial public offering of Class A Common Stock (the \"IPO\"). Each shares of Series C Preferred Stock automatically converted into Class A Common Stock on a 1.1869358:1 basis immediately prior to the completion of the Issuer's IPO. The right to convert Common Stock, Series A Preferred Stock, Series A-1 Preferred Stock, Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock into Class A Common Stock had no expiration date."},{"field":"shares","element":"transactionShares","label":"F8","text":"Represents shares held of record by Lux Ventures IV, L.P."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Each share of Common Stock, Series A Preferred Stock, Series A-1 Preferred Stock, Series B Preferred Stock and Series D Preferred Stock automatically converted into Class A Common Stock on a 1:1 basis immediately prior to the completion of Recursion Pharmaceuticals, Inc.'s (the \"Issuer\") initial public offering of Class A Common Stock (the \"IPO\"). Each shares of Series C Preferred Stock automatically converted into Class A Common Stock on a 1.1869358:1 basis immediately prior to the completion of the Issuer's IPO. The right to convert Common Stock, Series A Preferred Stock, Series A-1 Preferred Stock, Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock into Class A Common Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Each share of Common Stock, Series A Preferred Stock, Series A-1 Preferred Stock, Series B Preferred Stock and Series D Preferred Stock automatically converted into Class A Common Stock on a 1:1 basis immediately prior to the completion of Recursion Pharmaceuticals, Inc.'s (the \"Issuer\") initial public offering of Class A Common Stock (the \"IPO\"). Each shares of Series C Preferred Stock automatically converted into Class A Common Stock on a 1.1869358:1 basis immediately prior to the completion of the Issuer's IPO. The right to convert Common Stock, Series A Preferred Stock, Series A-1 Preferred Stock, Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock into Class A Common Stock had no expiration date."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F5","text":"Each share of Common Stock, Series A Preferred Stock, Series A-1 Preferred Stock, Series B Preferred Stock and Series D Preferred Stock automatically converted into Class A Common Stock on a 1:1 basis immediately prior to the completion of Recursion Pharmaceuticals, Inc.'s (the \"Issuer\") initial public offering of Class A Common Stock (the \"IPO\"). Each shares of Series C Preferred Stock automatically converted into Class A Common Stock on a 1.1869358:1 basis immediately prior to the completion of the Issuer's IPO. The right to convert Common Stock, Series A Preferred Stock, Series A-1 Preferred Stock, Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock into Class A Common Stock had no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F8","text":"Represents shares held of record by Lux Ventures IV, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Lux Co-Invest Partners, LLC is the general partner of Lux Co-Invest Opportunities, L.P. and exercises voting and dispositive power over the shares noted herein held by Lux Co-Invest Opportunities, L.P. Lux Venture Partners IV, LLC is the general partner of Lux Ventures IV, LP and exercises voting and dispositive power over the shares noted herein held by Lux Ventures IV, L.P. Peter Hebert and Josh Wolfe are the individual managing members of Lux Venture Partners IV, LLC and Lux Co-Invest Partners, LLC, or the Individual Managers. The Individual Managers, as the sole managers of Lux Venture Partners IV, LLC and Lux Co-Invest Partners, LLC, may be deemed to share voting and dispositive power for the shares noted herein held by Lux Ventures IV, L.P. and Lux Co-Invest Opportunities, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Each of Lux Venture Partners IV, LLC, Lux Co-Invest Partners, LLC, and the Individual Managers separately disclaim beneficial ownership over the shares noted herein except to the extent of their pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3578653},"source":{"system":"sec-edgar","filing":"0001209191-21-027701","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1722021/000120919121027701/doc4.xml","form_type":"4"}},{"id":2744041,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":124765,"kind":"organization","name":"Lux Ventures IV, L.P.","position":1,"cik":"0001633331","reported_name":"Lux Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124766,"kind":"organization","name":"Lux Co-Invest Opportunities, L.P.","position":2,"cik":"0001722022","reported_name":"Lux Co-Invest Opportunities, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124768,"kind":"organization","name":"Lux Co-Invest Partners, LLC","position":3,"cik":"0001722021","reported_name":"Lux Co-Invest Partners, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124767,"kind":"organization","name":"Lux Venture Partners IV, LLC","position":4,"cik":"0001633332","reported_name":"Lux Venture Partners IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Preferred Stock","published_at":"2021-04-20T21:30:12.000Z","date":"2021-04-20","kind":"exercise","acquired":false,"shares":10279275,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each share of Common Stock, Series A Preferred Stock, Series A-1 Preferred Stock, Series B Preferred Stock and Series D Preferred Stock automatically converted into Class A Common Stock on a 1:1 basis immediately prior to the completion of Recursion Pharmaceuticals, Inc.'s (the \"Issuer\") initial public offering of Class A Common Stock (the \"IPO\"). Each shares of Series C Preferred Stock automatically converted into Class A Common Stock on a 1.1869358:1 basis immediately prior to the completion of the Issuer's IPO. The right to convert Common Stock, Series A Preferred Stock, Series A-1 Preferred Stock, Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock into Class A Common Stock had no expiration date."},{"field":"shares","element":"transactionShares","label":"F8","text":"Represents shares held of record by Lux Ventures IV, L.P."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Each share of Common Stock, Series A Preferred Stock, Series A-1 Preferred Stock, Series B Preferred Stock and Series D Preferred Stock automatically converted into Class A Common Stock on a 1:1 basis immediately prior to the completion of Recursion Pharmaceuticals, Inc.'s (the \"Issuer\") initial public offering of Class A Common Stock (the \"IPO\"). Each shares of Series C Preferred Stock automatically converted into Class A Common Stock on a 1.1869358:1 basis immediately prior to the completion of the Issuer's IPO. The right to convert Common Stock, Series A Preferred Stock, Series A-1 Preferred Stock, Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock into Class A Common Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Each share of Common Stock, Series A Preferred Stock, Series A-1 Preferred Stock, Series B Preferred Stock and Series D Preferred Stock automatically converted into Class A Common Stock on a 1:1 basis immediately prior to the completion of Recursion Pharmaceuticals, Inc.'s (the \"Issuer\") initial public offering of Class A Common Stock (the \"IPO\"). Each shares of Series C Preferred Stock automatically converted into Class A Common Stock on a 1.1869358:1 basis immediately prior to the completion of the Issuer's IPO. The right to convert Common Stock, Series A Preferred Stock, Series A-1 Preferred Stock, Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock into Class A Common Stock had no expiration date."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F5","text":"Each share of Common Stock, Series A Preferred Stock, Series A-1 Preferred Stock, Series B Preferred Stock and Series D Preferred Stock automatically converted into Class A Common Stock on a 1:1 basis immediately prior to the completion of Recursion Pharmaceuticals, Inc.'s (the \"Issuer\") initial public offering of Class A Common Stock (the \"IPO\"). Each shares of Series C Preferred Stock automatically converted into Class A Common Stock on a 1.1869358:1 basis immediately prior to the completion of the Issuer's IPO. The right to convert Common Stock, Series A Preferred Stock, Series A-1 Preferred Stock, Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock into Class A Common Stock had no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F8","text":"Represents shares held of record by Lux Ventures IV, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Lux Co-Invest Partners, LLC is the general partner of Lux Co-Invest Opportunities, L.P. and exercises voting and dispositive power over the shares noted herein held by Lux Co-Invest Opportunities, L.P. Lux Venture Partners IV, LLC is the general partner of Lux Ventures IV, LP and exercises voting and dispositive power over the shares noted herein held by Lux Ventures IV, L.P. Peter Hebert and Josh Wolfe are the individual managing members of Lux Venture Partners IV, LLC and Lux Co-Invest Partners, LLC, or the Individual Managers. The Individual Managers, as the sole managers of Lux Venture Partners IV, LLC and Lux Co-Invest Partners, LLC, may be deemed to share voting and dispositive power for the shares noted herein held by Lux Ventures IV, L.P. and Lux Co-Invest Opportunities, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Each of Lux Venture Partners IV, LLC, Lux Co-Invest Partners, LLC, and the Individual Managers separately disclaim beneficial ownership over the shares noted herein except to the extent of their pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":10279275},"source":{"system":"sec-edgar","filing":"0001209191-21-027701","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1722021/000120919121027701/doc4.xml","form_type":"4"}},{"id":2744040,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":124765,"kind":"organization","name":"Lux Ventures IV, L.P.","position":1,"cik":"0001633331","reported_name":"Lux Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124766,"kind":"organization","name":"Lux Co-Invest Opportunities, L.P.","position":2,"cik":"0001722022","reported_name":"Lux Co-Invest Opportunities, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124768,"kind":"organization","name":"Lux Co-Invest Partners, LLC","position":3,"cik":"0001722021","reported_name":"Lux Co-Invest Partners, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124767,"kind":"organization","name":"Lux Venture Partners IV, LLC","position":4,"cik":"0001633332","reported_name":"Lux Venture Partners IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2021-04-20T21:30:12.000Z","date":"2021-04-20","kind":"exercise","acquired":true,"shares":17187095,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F6","text":"3,068,510 of these shares are held by Lux Co-Invest Opportunities, L.P. and 14,206,084 of these shares are held by Lux Ventures IV, L.P."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Pursuant to a reclassification exempt under Rule 16b-7, each share of Common Stock was automatically reclassified into one share of Class A Common Stock immediately prior to the completion of the Issuer's IPO."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"3,068,510 of these shares are held by Lux Co-Invest Opportunities, L.P. and 14,206,084 of these shares are held by Lux Ventures IV, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Lux Co-Invest Partners, LLC is the general partner of Lux Co-Invest Opportunities, L.P. and exercises voting and dispositive power over the shares noted herein held by Lux Co-Invest Opportunities, L.P. Lux Venture Partners IV, LLC is the general partner of Lux Ventures IV, LP and exercises voting and dispositive power over the shares noted herein held by Lux Ventures IV, L.P. Peter Hebert and Josh Wolfe are the individual managing members of Lux Venture Partners IV, LLC and Lux Co-Invest Partners, LLC, or the Individual Managers. The Individual Managers, as the sole managers of Lux Venture Partners IV, LLC and Lux Co-Invest Partners, LLC, may be deemed to share voting and dispositive power for the shares noted herein held by Lux Ventures IV, L.P. and Lux Co-Invest Opportunities, L.P."}],"balance_after":17287095,"source":{"system":"sec-edgar","filing":"0001209191-21-027701","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1722021/000120919121027701/doc4.xml","form_type":"4"}},{"id":2744039,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":124765,"kind":"organization","name":"Lux Ventures IV, L.P.","position":1,"cik":"0001633331","reported_name":"Lux Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124766,"kind":"organization","name":"Lux Co-Invest Opportunities, L.P.","position":2,"cik":"0001722022","reported_name":"Lux Co-Invest Opportunities, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124768,"kind":"organization","name":"Lux Co-Invest Partners, LLC","position":3,"cik":"0001722021","reported_name":"Lux Co-Invest Partners, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124767,"kind":"organization","name":"Lux Venture Partners IV, LLC","position":4,"cik":"0001633332","reported_name":"Lux Venture Partners IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-04-20T21:30:12.000Z","date":"2021-04-20","kind":"exercise","acquired":false,"shares":17187095,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F6","text":"3,068,510 of these shares are held by Lux Co-Invest Opportunities, L.P. and 14,206,084 of these shares are held by Lux Ventures IV, L.P."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Pursuant to a reclassification exempt under Rule 16b-7, each share of Common Stock was automatically reclassified into one share of Class A Common Stock immediately prior to the completion of the Issuer's IPO."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Lux Co-Invest Partners, LLC is the general partner of Lux Co-Invest Opportunities, L.P. and exercises voting and dispositive power over the shares noted herein held by Lux Co-Invest Opportunities, L.P. Lux Venture Partners IV, LLC is the general partner of Lux Ventures IV, LP and exercises voting and dispositive power over the shares noted herein held by Lux Ventures IV, L.P. Peter Hebert and Josh Wolfe are the individual managing members of Lux Venture Partners IV, LLC and Lux Co-Invest Partners, LLC, or the Individual Managers. The Individual Managers, as the sole managers of Lux Venture Partners IV, LLC and Lux Co-Invest Partners, LLC, may be deemed to share voting and dispositive power for the shares noted herein held by Lux Ventures IV, L.P. and Lux Co-Invest Opportunities, L.P."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-21-027701","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1722021/000120919121027701/doc4.xml","form_type":"4"}},{"id":2744038,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":124765,"kind":"organization","name":"Lux Ventures IV, L.P.","position":1,"cik":"0001633331","reported_name":"Lux Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124766,"kind":"organization","name":"Lux Co-Invest Opportunities, L.P.","position":2,"cik":"0001722022","reported_name":"Lux Co-Invest Opportunities, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124768,"kind":"organization","name":"Lux Co-Invest Partners, LLC","position":3,"cik":"0001722021","reported_name":"Lux Co-Invest Partners, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124767,"kind":"organization","name":"Lux Venture Partners IV, LLC","position":4,"cik":"0001633332","reported_name":"Lux Venture Partners IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-04-20T21:30:12.000Z","date":"2021-04-20","kind":"exercise","acquired":true,"shares":17174594,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"3,018,510 of these shares are held by Lux Co-Invest Opportunities, L.P. and 14,156,084 of these shares are held by Lux Ventures IV, L.P."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Each share of Common Stock, Series A Preferred Stock, Series A-1 Preferred Stock, Series B Preferred Stock and Series D Preferred Stock automatically converted into Class A Common Stock on a 1:1 basis immediately prior to the completion of Recursion Pharmaceuticals, Inc.'s (the \"Issuer\") initial public offering of Class A Common Stock (the \"IPO\"). Each shares of Series C Preferred Stock automatically converted into Class A Common Stock on a 1.1869358:1 basis immediately prior to the completion of the Issuer's IPO. The right to convert Common Stock, Series A Preferred Stock, Series A-1 Preferred Stock, Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock into Class A Common Stock had no expiration date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"3,068,510 of these shares are held by Lux Co-Invest Opportunities, L.P. and 14,206,084 of these shares are held by Lux Ventures IV, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Lux Co-Invest Partners, LLC is the general partner of Lux Co-Invest Opportunities, L.P. and exercises voting and dispositive power over the shares noted herein held by Lux Co-Invest Opportunities, L.P. Lux Venture Partners IV, LLC is the general partner of Lux Ventures IV, LP and exercises voting and dispositive power over the shares noted herein held by Lux Ventures IV, L.P. Peter Hebert and Josh Wolfe are the individual managing members of Lux Venture Partners IV, LLC and Lux Co-Invest Partners, LLC, or the Individual Managers. The Individual Managers, as the sole managers of Lux Venture Partners IV, LLC and Lux Co-Invest Partners, LLC, may be deemed to share voting and dispositive power for the shares noted herein held by Lux Ventures IV, L.P. and Lux Co-Invest Opportunities, L.P."}],"balance_after":17187095,"source":{"system":"sec-edgar","filing":"0001209191-21-027701","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1722021/000120919121027701/doc4.xml","form_type":"4"}},{"id":2744037,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":124765,"kind":"organization","name":"Lux Ventures IV, L.P.","position":1,"cik":"0001633331","reported_name":"Lux Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124766,"kind":"organization","name":"Lux Co-Invest Opportunities, L.P.","position":2,"cik":"0001722022","reported_name":"Lux Co-Invest Opportunities, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124768,"kind":"organization","name":"Lux Co-Invest Partners, LLC","position":3,"cik":"0001722021","reported_name":"Lux Co-Invest Partners, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124767,"kind":"organization","name":"Lux Venture Partners IV, LLC","position":4,"cik":"0001633332","reported_name":"Lux Venture Partners IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2021-04-20T21:30:12.000Z","date":"2021-04-16","kind":"purchase","acquired":true,"shares":100000,"price":18,"value":1800000.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"50,000 of these shares are held by Lux Co-Invest Opportunities, L.P. and 50,000 of these shares are held by Lux Ventures IV, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Lux Co-Invest Partners, LLC is the general partner of Lux Co-Invest Opportunities, L.P. and exercises voting and dispositive power over the shares noted herein held by Lux Co-Invest Opportunities, L.P. Lux Venture Partners IV, LLC is the general partner of Lux Ventures IV, LP and exercises voting and dispositive power over the shares noted herein held by Lux Ventures IV, L.P. Peter Hebert and Josh Wolfe are the individual managing members of Lux Venture Partners IV, LLC and Lux Co-Invest Partners, LLC, or the Individual Managers. The Individual Managers, as the sole managers of Lux Venture Partners IV, LLC and Lux Co-Invest Partners, LLC, may be deemed to share voting and dispositive power for the shares noted herein held by Lux Ventures IV, L.P. and Lux Co-Invest Opportunities, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Each of Lux Venture Partners IV, LLC, Lux Co-Invest Partners, LLC, and the Individual Managers separately disclaim beneficial ownership over the shares noted herein except to the extent of their pecuniary interest therein."}],"balance_after":100000,"source":{"system":"sec-edgar","filing":"0001209191-21-027701","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1722021/000120919121027701/doc4.xml","form_type":"4"}}]}